Interim Report January-September 2026

In Q3 2026, net sales rose 1.9% year over year to SEK 5,793 million, while EBITA excluding items affecting comparability increased to SEK 392 million from SEK 362 million and the margin expanded to 6.8% from 6.4%. The order backlog grew to SEK 22.1 billion from SEK 20.4 billion, although organic growth adjusted for calendar effects was -1.5%. The article text ends before the reported total EBITA figure.

Analysis

The quality of earnings appears better than the top-line trajectory: improved utilization and margin suggest capacity discipline or a more favorable delivery mix, but do not yet establish durable pricing power. If demand is still contracting organically, further margin gains may become harder once utilization plateaus; wage inflation or bench costs could then reverse the operating improvement. The larger backlog is a potential revenue bridge, not proof of future growth: conversion timing, cancellation terms, project mix and pricing determine whether it supports earnings or merely ties up delivery capacity.

Near term, the margin improvement may support sentiment, while weak underlying growth caps re-rating potential. Over the next 1–3 months, conversion of backlog into recognized sales and the next utilization reading are the key tests. Over 6–18 months, sustained growth depends on demand recovery and whether the company can maintain margins without relying on further utilization gains. The release is truncated and provides no company identity, segment detail, cash-flow data or guidance, so peer-specific positioning and valuation conclusions are not supportable. A sharp reversal in utilization or EBITA margin, or evidence of backlog slippage, would falsify the constructive operating-quality read.

Key Decisions for Investors

• No single-name trade on this excerpt alone: first verify the issuer, full release, segment trends, guidance, cash conversion and backlog conversion/cancellation terms.
• Treat a positive initial reaction as a quality-of-earnings signal rather than a growth inflection. If the stock rallies materially, avoid chasing until organic demand and backlog conversion confirm; reassess on the next report.
• Set a 1–3 month alert for utilization, organic sales and EBITA margin. Improving sales alongside stable margins would strengthen the constructive case; falling utilization or margin despite backlog would argue the backlog is not translating into profitable work.
• For a potential 6–18 month long thesis, require evidence that backlog converts into revenue without margin dilution and that cash flow tracks reported earnings. Otherwise, improved margins may prove cyclical and the lack of organic growth may constrain valuation.